RSV Infection Clinical Trials

77 clinical trials for RSV Infection across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose — RECRUITING · PHASE3
• A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus — RECRUITING · PHASE2
• RSV Burden in Outpatient and Hospital Settings — RECRUITING · NA
• Real-World Effectiveness of Perinatal RSV Immunoprophylaxis — RECRUITING
• Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France — RECRUITING
• Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults — RECRUITING · PHASE1
• RSV Vaccination in Immunocompromised Patients. — RECRUITING · PHASE2
• Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection — RECRUITING
• Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization — RECRUITING
• A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 18 Years or Above (DAN-RSV) — TERMINATED · PHASE4
• Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age — COMPLETED · PHASE1
• SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42) — COMPLETED
• Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection — TERMINATED · PHASE2
• Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test — COMPLETED · NA
• Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment — COMPLETED · NA
• Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection — TERMINATED · PHASE2
• Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) — COMPLETED · PHASE3
• CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools — ACTIVE_NOT_RECRUITING
• Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children — COMPLETED · PHASE1
• The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus — COMPLETED · NA
• Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China — ACTIVE_NOT_RECRUITING
• Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years — COMPLETED · PHASE1
• A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model — COMPLETED · PHASE2
• A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV — COMPLETED · PHASE1
• A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults — COMPLETED · PHASE1
• A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants — COMPLETED · PHASE1
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — COMPLETED · PHASE2
• Immunogenicity after a prime dose and revaccination with adjuvanted RSVPreF3 vaccine in the most elderly and frail population – an open-labeled phase IIIb-trial RSV Immunogenicity Study in the Elderly (RISE) — NOT_YET_RECRUITING · PHASE3
• A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. — COMPLETED · PHASE1
• Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit — COMPLETED
• A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Emission Patterns of Respiratory Syncytial Virus — TERMINATED
• Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study — COMPLETED
• Safety and Immunogenicity Study of SCB-1019T in Children — WITHDRAWN · PHASE1
• Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children — COMPLETED · PHASE1
• An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute) — OTHER
• Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults — COMPLETED · PHASE1
• Project STARFISH - PRJ0002679 — COMPLETED
• Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan — OTHER
• Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands — OTHER
• Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control — OTHER
• Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis. — OTHER · NA
• Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis — OTHER
• Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children — COMPLETED · PHASE2
• A Study of EDP-323 in Healthy Subjects — COMPLETED · PHASE1
• Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults — COMPLETED · PHASE2
• FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol — OTHER
• Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV — WITHDRAWN · PHASE2
• Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens. — OTHER · NA

Refine this search